![Hewmun Lau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hewmun Lau
Private Equity Investor bei Broadview Ventures, Inc.
Profil
Hewmun Lau is currently working as a Principal at Broadview Ventures, Inc. Prior to this, she worked as a Director at Merrimack Pharmaceuticals, Inc. from 2017 to 2019 and as a Senior Consultant at Navigant Consulting Group, Inc. from 2012 to 2015.
Ms. Lau has an MBA from Massachusetts Institute of Technology, an undergraduate degree from Brandeis University, and a graduate degree from Harvard Mit Health Sciences & Technology.
Aktive Positionen von Hewmun Lau
Unternehmen | Position | Beginn |
---|---|---|
Broadview Ventures, Inc.
![]() Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01.05.2019 |
Ehemalige bekannte Positionen von Hewmun Lau
Unternehmen | Position | Ende |
---|---|---|
MERRIMACK PHARMACEUTICALS, INC. | Private Equity Investor | 31.03.2019 |
Navigant Consulting Group, Inc. | Berater | 01.10.2015 |
Ausbildung von Hewmun Lau
Brandeis University | Undergraduate Degree |
Harvard Mit Health Sciences & Technology | Graduate Degree |
Massachusetts Institute of Technology | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Broadview Ventures, Inc.
![]() Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts. | Finance |
Merrimack Pharmaceuticals, Inc.
![]() Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Navigant Consulting Group, Inc. |